Table 1.
Before substitutive treatment | After substitutive treatment (12 weeks) |
Reference ranges |
|
---|---|---|---|
TSH | |||
Patient 1 | 396,5 | 24 | 0,25 - 4 (mUI/l) |
Patient 2 | 23.4 | 5 | |
Hemoglobin | |||
Patient 1 | 11.2 | 12.3 | 13-16 g/dl |
Patient 2 | 13.1 | 13.2 | |
CPK | |||
Patient 1 | 496 | 100 | < 250 (UI/l) |
Patient 2 | 550 | 230 | |
Cholesterolemia | |||
Patient 1 | 6,72 | 5.8 | < 5,5 (mmol/l) |
Patient 2 | 7.1 | 5,7 | |
Ejection fraction | |||
Patient 1 | 20% | 49% | 55% |
Patient 2 | 25% | 47% |
TSH: thyroid stimulating hormone
CPK: creatin phosphokinase